These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15794955)

  • 41. Public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002.
    Chang ML; Vitek C; Esparza J;
    AIDS; 2003 Oct; 17(15):W1-10. PubMed ID: 14523295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is an effective HIV vaccine feasible?
    Cohen J
    Science; 2005 Jul; 309(5731):99. PubMed ID: 15994545
    [No Abstract]   [Full Text] [Related]  

  • 43. [There will not be an AIDS vaccine].
    Rozenbaum W
    Soins; 2004; (687):52. PubMed ID: 15384782
    [No Abstract]   [Full Text] [Related]  

  • 44. First AIDS vaccine: better than nothing.
    Park A
    Time; 1998 Jun; 151(23):66. PubMed ID: 10181037
    [No Abstract]   [Full Text] [Related]  

  • 45. 'Money down the drain' fears for AIDS vaccine trials.
    Nature; 2003 Nov; 426(6964):220-1. PubMed ID: 14628016
    [No Abstract]   [Full Text] [Related]  

  • 46. AIDS vaccine on test in India.
    Ojcius D
    Nat Rev Microbiol; 2005 Mar; 3(3):198. PubMed ID: 15742524
    [No Abstract]   [Full Text] [Related]  

  • 47. New hope for an AIDS vaccine.
    Robinson HL
    Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine against AIDS?
    Lancet; 1994 Feb; 343(8896):493-4. PubMed ID: 7906752
    [No Abstract]   [Full Text] [Related]  

  • 49. Uganda to host AIDS vaccine therapy trials.
    Science; 1992 Aug; 257(5071):742. PubMed ID: 1496394
    [No Abstract]   [Full Text] [Related]  

  • 50. AIDS wins this round.
    Park A
    Time; 2007 Nov; 170(21):55. PubMed ID: 18074642
    [No Abstract]   [Full Text] [Related]  

  • 51. The ethics of AIDS vaccine trials.
    Zion D
    Science; 1998 May; 280(5368):1329-30; author reply 1330-1. PubMed ID: 9634405
    [No Abstract]   [Full Text] [Related]  

  • 52. Candidate AIDS vaccines.
    Graham BS; Wright PF
    N Engl J Med; 1995 Nov; 333(20):1331-9. PubMed ID: 7566026
    [No Abstract]   [Full Text] [Related]  

  • 53. Imperfect vaccines and herd immunity to HIV.
    McLean AR; Blower SM
    Proc Biol Sci; 1993 Jul; 253(1336):9-13. PubMed ID: 8396781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Government cancels testing of experimental AIDS vaccine; large-scale study to be scaled back after similar drug failed.
    AIDS Read; 2008 Aug; 18(8):396. PubMed ID: 18770896
    [No Abstract]   [Full Text] [Related]  

  • 55. Newborn baby AIDS vaccine program.
    Md Med J; 1994 Dec; 43(12):1040. PubMed ID: 7815906
    [No Abstract]   [Full Text] [Related]  

  • 56. AIDS clinical trials at John Hopkins.
    Hopkins HIV Rep; 2000 Jan; 12(1):suppl 1-4. PubMed ID: 11366319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seth Berkley--accelerating AIDS vaccine development [interviewed by Marilynn Larkin].
    Berkley S
    Lancet Infect Dis; 2005 Jan; 5(1):16-9. PubMed ID: 15620556
    [No Abstract]   [Full Text] [Related]  

  • 58. AIDS vaccine trial begins in Uganda.
    Mayor S
    BMJ; 2003 Feb; 326(7386):414. PubMed ID: 12595362
    [No Abstract]   [Full Text] [Related]  

  • 59. AIDS research. Did Merck's failed HIV vaccine cause harm?
    Cohen J
    Science; 2007 Nov; 318(5853):1048-9. PubMed ID: 18006711
    [No Abstract]   [Full Text] [Related]  

  • 60. How should the potency of HIV vaccine candidates be determined?
    Sheets R; Bean P
    Am Clin Lab; 2000; 19(8):23. PubMed ID: 11146989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.